{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:06:44Z","timestamp":1792516004222,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["T\u00e9l\u00e9vie #7.4544.18"],"award-info":[{"award-number":["T\u00e9l\u00e9vie #7.4544.18"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013845","name":"Fondation contre le Cancer","doi-asserted-by":"publisher","award":["#2018-078"],"award-info":[{"award-number":["#2018-078"]}],"id":[{"id":"10.13039\/501100013845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12770-0","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:02:41Z","timestamp":1724130161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Spatial transcriptomics profiling of gallbladder adenocarcinoma: a detailed two-case study of progression from precursor lesions to cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Sophie","family":"Pirenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Manzano-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Komuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric P.","family":"Lemaigre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"12770_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","volume":"521","author":"J Huang","year":"2021","unstructured":"Huang J, Patel HK, Boakye D, Chandrasekar VT, Koulaouzidis A, Lucero-Prisno Iii DE, et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis. Cancer Lett. 2021;521:238\u201351.","journal-title":"Cancer Lett"},{"key":"12770_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garcia P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8:69.","journal-title":"Nat Rev Dis Primers"},{"key":"12770_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12253-014-9886-3","volume":"21","author":"MM Bal","year":"2015","unstructured":"Bal MM, Ramadwar M, Deodhar K, Shrikhande S. Pathology of gallbladder carcinoma: current understanding and new perspectives. Pathol Oncol Res. 2015;21:509\u201325.","journal-title":"Pathol Oncol Res"},{"key":"12770_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5858\/2005-129-386-PPOGDA","volume":"129","author":"S Mukhopadhyay","year":"2005","unstructured":"Mukhopadhyay S, Landas SK. Putative precursors of gallbladder dysplasia: a review of 400 routinely resected specimens. Arch Pathol Lab Med. 2005;129:386\u201390.","journal-title":"Arch Pathol Lab Med"},{"key":"12770_CR5","first-page":"26","volume":"6","author":"C Seretis","year":"2014","unstructured":"Seretis C, Lagoudianakis E, Gemenetzis G, Seretis F, Pappas A, Gourgiotis S. Metaplastic changes in chronic cholecystitis: implications for early diagnosis and surgical intervention to prevent the gallbladder metaplasia-dysplasia-carcinoma sequence. J Clin Med Res. 2014;6:26\u20139.","journal-title":"J Clin Med Res"},{"key":"12770_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/his.14360","volume":"79","author":"JC Roa","year":"2021","unstructured":"Roa JC, Basturk O, Adsay V. Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications. Histopathology. 2021;79:2\u201319.","journal-title":"Histopathology"},{"key":"12770_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/diagnostics12020341","volume":"12","author":"Y Fukumura","year":"2022","unstructured":"Fukumura Y, Rong L, Maimaitiaili Y, Fujisawa T, Isayama H, Nakahodo J, et al. Precursor lesions of gallbladder carcinoma: disease concept, pathology, and genetics. Diagnostics (Basel). 2022;12:341.","journal-title":"Diagnostics (Basel)"},{"key":"12770_CR8","doi-asserted-by":"crossref","unstructured":"Manzano-N\u00fa\u00f1ez F, Prates Tiago Aguilar L, Sempoux C, Lemaigre FP. Biliary tract cancer: molecular biology of precursor lesions. Semin Liver Dis, 43:472\u201384.","DOI":"10.1055\/a-2207-9834"},{"key":"12770_CR9","unstructured":"Basturk O, Aishima S, Esposito I. Biliary intraepithelial neoplasia. In: WHO Classification of tumours editors. Digestive system tumours, 5th edition; 2019. pp. 273\u2013275."},{"key":"12770_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.32074\/1591-951X-251","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato S, Sacchi D, Fassan M, Fabris L, Cadamuro M, Zanus G, et al. Benign biliary neoplasms and biliary tumor precursors. Pathologica. 2021;113:147\u201357.","journal-title":"Pathologica"},{"key":"12770_CR11","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3390\/cancers14215358","volume":"14","author":"Y Nakanuma","year":"2022","unstructured":"Nakanuma Y, Kakuda Y, Sugino T, Sato Y, Fukumura Y. Pathologies of precursor lesions of biliary tract carcinoma. Cancers (Basel). 2022;14:5358.","journal-title":"Cancers (Basel)"},{"key":"12770_CR12","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/cncr.27955","volume":"119","author":"M Hsu","year":"2013","unstructured":"Hsu M, Sasaki M, Igarashi S, Sato Y, Nakanuma Y. KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer. 2013;119:1669\u201374.","journal-title":"Cancer"},{"key":"12770_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1665-2681(19)32065-4","volume":"4","author":"M Moreno","year":"2005","unstructured":"Moreno M, Pimentel F, Gazdar AF, Wistuba II, Miquel JF. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Ann Hepatol. 2005;4:192\u20139.","journal-title":"Ann Hepatol"},{"key":"12770_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0046-8177(96)90109-4","volume":"27","author":"II Wistuba","year":"1996","unstructured":"Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol. 1996;27:360\u20135.","journal-title":"Hum Pathol"},{"key":"12770_CR15","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1038\/s41467-021-25012-9","volume":"12","author":"J Lin","year":"2021","unstructured":"Lin J, Peng X, Dong K, Long J, Guo X, Li H, et al. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun. 2021;12:4753.","journal-title":"Nat Commun"},{"key":"12770_CR16","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1002\/ctm2.462","volume":"11","author":"P Chen","year":"2021","unstructured":"Chen P, Wang Y, Li J, Bo X, Wang J, Nan L, et al. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing. Clin Transl Med. 2021;11:e462.","journal-title":"Clin Transl Med"},{"key":"12770_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","volume":"75","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zuo C, Liu L, Hu Y, Yang B, Qiu S, et al. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer. J Hepatol. 2021;75:1128\u201341.","journal-title":"J Hepatol"},{"key":"12770_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet. 2013;45:1470\u20133.","journal-title":"Nat Genet"},{"key":"12770_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872\u20136.","journal-title":"Nat Genet"},{"key":"12770_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, et al. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47:1003\u201310.","journal-title":"Nat Genet"},{"key":"12770_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R, et al. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol. 2018;68:959\u201369.","journal-title":"J Hepatol"},{"key":"12770_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mrrev.2018.08.003","volume":"778","author":"R Mehrotra","year":"2018","unstructured":"Mehrotra R, Tulsyan S, Hussain S, Mittal B, Singh Saluja S, Singh S, et al. Genetic landscape of gallbladder cancer: global overview. Mutat Res. 2018;778:61\u201371.","journal-title":"Mutat Res"},{"key":"12770_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","volume":"73","author":"R Montal","year":"2020","unstructured":"Montal R, Sia D, Montironi C, Leow WQ, Esteban-Fabro R, Pinyol R, et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol. 2020;73:315\u201327.","journal-title":"J Hepatol"},{"key":"12770_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/cancers13040733","volume":"13","author":"N Ebata","year":"2021","unstructured":"Ebata N, Fujita M, Sasagawa S, Maejima K, Okawa Y, Hatanaka Y, et al. Molecular classification and tumor microenvironment characterization of gallbladder cancer by comprehensive genomic and transcriptomic analysis. Cancers (Basel). 2021;13:733.","journal-title":"Cancers (Basel)"},{"key":"12770_CR25","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.3390\/cancers13215257","volume":"13","author":"H Kuipers","year":"2021","unstructured":"Kuipers H, de Bitter TJJ, de Boer MT, van der Post RS, Nijkamp MW, de Reuver PR, et al. Gallbladder cancer: current insights in genetic alterations and their possible therapeutic implications. Cancers (Basel). 2021;13:5257.","journal-title":"Cancers (Basel)"},{"key":"12770_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","volume":"74","author":"C Nepal","year":"2021","unstructured":"Nepal C, Zhu B, O\u2019Rourke CJ, Bhatt DK, Lee D, Song L, et al. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol. 2021;74:1132\u201344.","journal-title":"J Hepatol"},{"key":"12770_CR27","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1158\/1078-0432.CCR-04-0579","volume":"10","author":"T Takahashi","year":"2004","unstructured":"Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004;10:6126\u201333.","journal-title":"Clin Cancer Res"},{"key":"12770_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mc.20457","volume":"48","author":"P Garcia","year":"2009","unstructured":"Garcia P, Manterola C, Araya JC, Villaseca M, Guzman P, Sanhueza A, et al. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions. Mol Carcinog. 2009;48:79\u201389.","journal-title":"Mol Carcinog"},{"key":"12770_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1021\/pr800641v","volume":"8","author":"MK Doherty","year":"2009","unstructured":"Doherty MK, Hammond DE, Clague MJ, Gaskell SJ, Beynon RJ. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. J Proteome Res. 2009;8:104\u201312.","journal-title":"J Proteome Res"},{"key":"12770_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1868-7083-4-11","volume":"4","author":"P Letelier","year":"2012","unstructured":"Letelier P, Brebi P, Tapia O, Roa JC. DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics. 2012;4:11.","journal-title":"Clin Epigenetics"},{"key":"12770_CR31","doi-asserted-by":"publisher","first-page":"14687","DOI":"10.1007\/s13277-016-5355-9","volume":"37","author":"P Sharma","year":"2016","unstructured":"Sharma P, Bhunia S, Poojary SS, Tekcham DS, Barbhuiya MA, Gupta S, et al. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. Tumour Biol. 2016;37:14687\u201399.","journal-title":"Tumour Biol"},{"key":"12770_CR32","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/hep.31585","volume":"73","author":"J Bragelmann","year":"2021","unstructured":"Bragelmann J, Barahona Ponce C, Marcelain K, Roessler S, Goeppert B, Gallegos I, et al. Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology. 2021;73:2293\u2013310.","journal-title":"Hepatology"},{"key":"12770_CR33","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza JA, Bizama C, Garcia P, Ferreccio C, Javle M, Miquel JF, et al. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta. 2016;1865:245\u201354.","journal-title":"Biochim Biophys Acta"},{"key":"12770_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fonc.2020.00823","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang J, Xu C, Cheng Q, Zhao J, Wu S, Li W, et al. RNA sequencing revealed signals of evolution from gallbladder stone to gallbladder carcinoma. Front Oncol. 2020;10:823.","journal-title":"Front Oncol"},{"key":"12770_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12038-022-00267-6","volume":"47","author":"N Roy","year":"2022","unstructured":"Roy N, Dihingia BR, Barah P. Integrative network-based approaches identified systems-level molecular signatures associated with gallbladder cancer pathogenesis from gallstone diseases. J Biosci. 2022;47:31.","journal-title":"J Biosci"},{"key":"12770_CR36","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/0008-5472.CAN-21-2176","volume":"82","author":"M Nagao","year":"2022","unstructured":"Nagao M, Fukuda A, Omatsu M, Namikawa M, Sono M, Fukunaga Y, et al. Concurrent activation of Kras and canonical wnt signaling induces premalignant lesions that progress to extrahepatic biliary cancer in mice. Cancer Res. 2022;82:1803\u201317.","journal-title":"Cancer Res"},{"key":"12770_CR37","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/path.6139","volume":"260","author":"M Namikawa","year":"2023","unstructured":"Namikawa M, Fukuda A, Mizukoshi K, Iwane K, Kawai M, Yamakawa G, et al. Simultaneous activation of Kras-akt and notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway. J Pathol. 2023;260:478\u201392.","journal-title":"J Pathol"},{"key":"12770_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt CR, Ong GT, Church SE, Barker K, Danaher P, Geiss G, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586\u201399.","journal-title":"Nat Biotechnol"},{"key":"12770_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.31252","volume":"73","author":"CA Rimland","year":"2021","unstructured":"Rimland CA, Tilson SG, Morell CM, Tomaz RA, Lu WY, Adams SE, et al. Regional differences in human biliary tissues and corresponding in vitro derived organoids. Hepatology. 2021;73:247\u201367.","journal-title":"Hepatology"},{"key":"12770_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"12770_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"12770_CR42","unstructured":"Roa JC, Adsay NV, Arola J, Tsui WM, Zen Y. Carcinoma of the gallbladder. In: WHO Classification of tumours editors. Digestive system tumours, 5th edition; 2019. p 283\u2013288."},{"key":"12770_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12770_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"12770_CR45","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1038\/ncomms6191","volume":"5","author":"E Schulz","year":"2014","unstructured":"Schulz E, Klampfl P, Holzapfel S, Janecke AR, Ulz P, Renner W, et al. Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nat Commun. 2014;5:5191.","journal-title":"Nat Commun"},{"key":"12770_CR46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/19336918.2016.1215785","volume":"10","author":"D Ito","year":"2016","unstructured":"Ito D, Kumanogoh A. The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems. Cell Adh Migr. 2016;10:692\u20139.","journal-title":"Cell Adh Migr"},{"key":"12770_CR47","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-019-13420-x","volume":"10","author":"S Xu","year":"2019","unstructured":"Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492.","journal-title":"Nat Commun"},{"key":"12770_CR48","doi-asserted-by":"publisher","first-page":"e78636","DOI":"10.7554\/eLife.78636","volume":"11","author":"M Kang","year":"2022","unstructured":"Kang M, Na HY, Ahn S, Kim JW, Lee S, Ahn S, et al. Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors. Elife. 2022;11:e78636.","journal-title":"Elife"},{"key":"12770_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","volume":"58","author":"J Song","year":"2020","unstructured":"Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME. Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol. 2020;58:134\u201349.","journal-title":"Clin Rev Allergy Immunol"},{"key":"12770_CR50","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/MIB.0b013e318281f49a","volume":"19","author":"MR Timmer","year":"2013","unstructured":"Timmer MR, Beuers U, Fockens P, Ponsioen CY, Rauws EA, Wang KK, Krishnadath KK. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma. Inflamm Bowel Dis. 2013;19:1789\u201397.","journal-title":"Inflamm Bowel Dis"},{"key":"12770_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/path.5994","volume":"258","author":"EJ Kamp","year":"2022","unstructured":"Kamp EJ, Dinjens WN, Doukas M, van Marion R, Verheij J, Ponsioen CY, et al. Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis. J Pathol. 2022;258:227\u201335.","journal-title":"J Pathol"},{"key":"12770_CR52","doi-asserted-by":"publisher","first-page":"e109221","DOI":"10.15252\/embj.2021109221","volume":"41","author":"R Vegliante","year":"2022","unstructured":"Vegliante R, Pastushenko I, Blanpain C. Deciphering functional tumor states at single-cell resolution. EMBO J. 2022;41:e109221.","journal-title":"EMBO J"},{"key":"12770_CR53","doi-asserted-by":"crossref","unstructured":"Roche J. The epithelial-to-mesenchymal transition in cancer. Cancers (Basel) 2018, 10:52.","DOI":"10.3390\/cancers10020052"},{"key":"12770_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41467-023-36439-7","volume":"14","author":"G Malagoli Tagliazucchi","year":"2023","unstructured":"Malagoli Tagliazucchi G, Wiecek AJ, Withnell E, Secrier M. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. Nat Commun. 2023;14:789.","journal-title":"Nat Commun"},{"key":"12770_CR55","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","volume":"40","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang S, Tavormina J, Tampe D, Zeisberg M, Wang H, et al. Oncogenic collagen I homotrimers from cancer cells bind to alpha3beta1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell. 2022;40:818\u201334.","journal-title":"Cancer Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12770-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T05:04:54Z","timestamp":1724130294000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12770"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12770-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.27.582232","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study on human samples was conducted in compliance with the ethical guidelines of the 2013 Declaration of Helsinki and was approved by the Comit\u00e9 d\u2019Ethique Hospitalo-Facultaire (UCLouvain and Cliniques Universitaires Saint-Luc) with numbers 2018\/06Jul\/281 and 2021\/26OCT\/444. In accordance with article 8 of the internal rules of the Cliniques universitaires Saint-Luc, the need for informed consent was waived to the present retrospective study. The study is based solely on the analysis of residual human body material and on the collection of data existing in the medical files of patients who have not expressed their opposition to the use of their medical file for scientific research purposes. An informed consent exemption request was thus presented to the Ethics Committee, which was accepted. Mice received humane care and the research protocol was approved by the Animal Welfare Committee of the Universit\u00e9 Catholique de Louvain with number 2022\/UCL\/MD\/17.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1025"}}